← Back to Search

Fitbit Tracking for Post-Surgery Ambulation

N/A
Recruiting
Led By Michael T Jaklitsch, MD
Research Sponsored by Dana-Farber Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 week
Awards & highlights

Study Summary

This trial is examining the feasibility of collecting data on steps walked per day from patients over 70 years old who are about to have surgery. The study is using the Fitbit Inspire device to track ambulation.

Who is the study for?
This trial is for people aged 65 or older who are scheduled for major lung surgery at Brigham and Women's Hospital. They must be able to walk and give consent, without urgent cardiac diseases that need testing or surgeries so immediate they can't wait for the study period.Check my eligibility
What is being tested?
The study is tracking how many steps patients over 65 take each day using a Fitbit Inspire before undergoing thoracic surgery. The goal is to collect data on their physical activity levels prior to the operation.See study design
What are the potential side effects?
Since this trial involves using a Fitbit device to monitor steps, there are no direct medical side effects expected from participating in this study.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 week
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 week for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Data Retrieval Rate
Diary of Steps Rate
Return Rate
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: PRE-OPERATIVE EXERCISE TRACKINGExperimental Treatment1 Intervention
Participant baseline information will be collected from their electronic medical records. After enrollment, participants will be provided a mobile device (Fitbit) to wear for tracking steps for 1 week prior to their scheduled surgery. Participants will keep a log of daily steps for the 1 week they are wearing the device and receive one progress check-in call during the week. The device and log will be turned in either on a pre-surgery clinic visit or on the day of surgery whichever comes first.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Fitbit
2021
N/A
~3560

Find a Location

Who is running the clinical trial?

Dana-Farber Cancer InstituteLead Sponsor
1,079 Previous Clinical Trials
340,950 Total Patients Enrolled
Michael T Jaklitsch, MDPrincipal InvestigatorBrigham and Women's Hospital
1 Previous Clinical Trials
27 Total Patients Enrolled

Media Library

Fitbit Clinical Trial Eligibility Overview. Trial Name: NCT04630496 — N/A
Thoracic Diseases Research Study Groups: PRE-OPERATIVE EXERCISE TRACKING
Thoracic Diseases Clinical Trial 2023: Fitbit Highlights & Side Effects. Trial Name: NCT04630496 — N/A
Fitbit 2023 Treatment Timeline for Medical Study. Trial Name: NCT04630496 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many people will this experiment test on in total?

"That is correct. The trial, which began recruitment on August 25th, 2021, is currently looking for 30 individuals from 2 locations, according to the listing on clinicaltrials.gov."

Answered by AI

Are there any current vacancies in this experiment for test subjects?

"The clinical trial is currently still recruiting patients, according to the information provided on clinicaltrials.gov. This particular trial was originally posted on August 25th, 2021 and was most recently updated on April 7th, 2022."

Answered by AI
~5 spots leftby Dec 2024